American Beacon Stephens Sm Cp Gr R6 (STSRX)

Fund Assets	525.41M
Expense Ratio	0.917%
Min. Investment	$100,000
Turnover	35.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	Annual
Ex-Dividend Date	Dec 22, 2025

Previous Close	17.04
YTD Return	12.61%
1-Year Return	10.19%
5-Year Return	23.87%
52-Week Low	14.49
52-Week High	18.61
Beta (5Y)	n/a
Holdings	99
Inception Date	Apr 30, 2019

About STSRX

The American Beacon Stephens Small Cap Growth Fund R6 is a mutual fund focused on achieving long-term capital growth by investing primarily in small-capitalization U.S. companies. Managed by Stephens Investment Management Group, the fund targets firms that are believed to have strong growth prospects, typically operating in sectors such as technology, healthcare, consumer defensive, and industrials. By concentrating on the small-cap segment, the fund aims to capitalize on perceived market inefficiencies and the potential for rapid business expansion within this space. The portfolio is diversified, with individual positions in a range of dynamic companies and a relatively modest concentration in its top holdings, helping to manage sector and stock-specific risks. The R6 share class is structured for institutional investors, offering a competitive expense ratio relative to its peer group. The fund’s investment style aligns with the small-growth category, employing fundamental analysis in its security selection process and benchmarking its performance against the Russell 2000 Growth Index. Its disciplined approach makes it a notable participant in the small-cap growth mutual fund market, providing access to companies positioned at the forefront of innovation and market trends.

• Fund Family: American Beacon
• Category: Small Growth
• Performance Rating: Above Average
• Risk Rating: Below Average
• Stock Exchange: Nasdaq
• Ticker Symbol: STSRX
• Share Class: R6 Class
• Index: Russell 2000 Growth TR

Performance

STSRX had a total return of 10.19% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.49%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
STSIX	R5 Class	0.99%
SPWYX	Y Class	1.05%
STSGX	Investor Class	1.27%
SPWAX	A Class	1.28%

Top 10 Holdings

18.56% of assets

Name	Symbol	Weight
Halozyme Therapeutics, Inc.	HALO	2.03%
Ligand Pharmaceuticals Incorporated	LGND	1.99%
Repligen Corporation	RGEN	1.93%
FirstCash Holdings, Inc.	FCFS	1.91%
Xometry, Inc.	XMTR	1.88%
Travere Therapeutics, Inc.	TVTX	1.84%
EZCORP, Inc.	EZPW	1.77%
Manhattan Associates, Inc.	MANH	1.76%
Twist Bioscience Corporation	TWST	1.73%
U.S. Government Money Market S	n/a	1.71%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 22, 2025	$1.3889	Dec 23, 2025
Dec 20, 2024	$0.9945	Dec 23, 2024
Dec 21, 2023	$0.1708	Dec 22, 2023
Dec 22, 2022	$1.4442	Dec 23, 2022
Dec 22, 2021	$3.6759	Dec 23, 2021
Dec 22, 2020	$1.9253	Dec 23, 2020

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Oct 16, 2026

Data Sources Report a data error